Foot Controlled Robotic Endoscope Enabled Robot FESS
- Conditions
- Polyp of Nasal SinusSinusitis
- Interventions
- Device: FREE robot
- Registration Number
- NCT03454607
- Lead Sponsor
- Chinese University of Hong Kong
- Brief Summary
To evaluate the safety and feasibility of a Foot Controlled Robotic Endoscope Enabled Robot (FREE) in performing functional endoscopic sinus surgery to answer the two key questions:
1. Is the FREE robot feasible to use in patients for endoscopic sinus surgery?
2. Is the FREE robot safe to use in patients for endoscopic sinus surgery?
- Detailed Description
Through previous cadaver experiments we have demonstrated and experimentally validated a new foot-controlled robotic endoscope holder prototype that allows the surgeon to directly manipulate surgical instruments with both hands at all times. The conducted ex-vivo cadaver test, corroborated the feasibility of the robotic prototype. However the next step requires further clinical trials to evaluate its use in endoscopic sinus surgery in patients that is the purpose of this study
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 1
- Undergoing FESS surgery for benign pathology
- Pregnant/ lactating female patients
- Younger than 18 years of age
- Cognitive impairment or unable to provide informed consent
- Malignant sinus pathologies
- Previous endoscopic sinus surgery
- Contraindication to general anaesthesia
- Untreated active infection
- Non-correctable coagulopathy
- Emergency Surgery
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description FREE robot FREE robot Patients undergoing sinus surgery with the FREE robot
- Primary Outcome Measures
Name Time Method Conversion Intraoperative The rate of conversions to normal holding of the endoscope
Perioperative complications Within 30 days postoperative Assessment of perioperative complications
- Secondary Outcome Measures
Name Time Method Surgical outcomes Intraoperative and postoperative 2 weeks and 30 days Estimated blood loss
Surgical Outcomes Intraoperative and postoperative 2 weeks and 30 days Length of stay
Quality of life Within 30 days postoperative The Total Nasal Symptom Score (TNSS; possible score of 0-12) is the sum of 4 individual participant-assessed symptom scores for rhinorrhea, nasal congestion, nasal itching, and sneezing, each evaluated using a scale of 0=None, 1=Mild, 2=Moderate, or 3=Severe. Higher scores represent a worse outcome
Trial Locations
- Locations (1)
The Chinese University of Hong Kong
ðŸ‡ðŸ‡°Shatin, Hong Kong